The ACIP made the recommendations below after the meeting.

A. Effective November 1, the Moderna bivalent vaccine (original and Omicron BA.1) can be offered to adolescents aged 12-17 as booster shots (including those who have not received a booster dose or who have received a booster dose of a monovalent vaccine).

B. The Moderna bivalent vaccine (original and Omicron BA.4/BA.5) was approved and authorized for use on people aged 12 and older by Taiwan's Food and Drug Administration (TFDA) on October 26. This vaccine will be offered to individuals aged 12 and older as booster shots depending on the vaccine supply.

C. If the Pfizer-BioNTech monovalent vaccine is authorized for use as a booster shot for children 5-11 years of age by TFDA, the Pfizer-BioNTech monovalent vaccine will be offered as booster shots for children in this age group.

Please click here to see further details.